VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,447 | -48.1% | 15,391 | +33.3% | 0.00% | – |
| Q2 2023 | $291,843 | +7.5% | 11,549 | +13.4% | 0.00% | – |
| Q4 2022 | $271,377 | -11.9% | 10,183 | -0.9% | 0.00% | – |
| Q3 2022 | $308,000 | +41.9% | 10,273 | +26.2% | 0.00% | – |
| Q2 2022 | $217,000 | -97.6% | 8,141 | -96.0% | 0.00% | -100.0% |
| Q3 2021 | $8,934,000 | +12138.4% | 205,896 | +12516.2% | 0.00% | – |
| Q1 2021 | $73,000 | -71.3% | 1,632 | -81.9% | 0.00% | – |
| Q4 2020 | $254,000 | +109.9% | 9,014 | +209.4% | 0.00% | – |
| Q3 2020 | $121,000 | -34.2% | 2,913 | -25.0% | 0.00% | – |
| Q2 2020 | $184,000 | +1433.3% | 3,886 | +886.3% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 394 | -56.5% | 0.00% | – |
| Q4 2019 | $11,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |